Skin Rashes Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Rashes, including details on dermatitis, itches, creams, medication, treatment.

Volume 2 (2005), Issue 6 (June)

1. A novel method to control the balance of skin microflora Part 2. A study to assess the effect of a cream containing farnesol and xylitol on atopic dry skin.
   J Dermatol Sci, 38(3): 207-13. [Abstract] [Full-text]
2. A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics.
   J Dermatol Sci, 38(3): 197-205. [Abstract] [Full-text]
3. Topical application of luteolin inhibits scratching behavior associated with allergic cutaneous reaction in mice.
   Planta Med, 71(5): 424-8. [Abstract] [Full-text]
4. The association of prolonged breastfeeding and allergic disease in poor urban children.
   Eur Respir J, 25(6): 970-7. [Abstract] [Full-text]
5. Multiple fixed drug eruption due to drug combination.
   Contact Dermatitis, 52(6): 339-41. [Abstract] [Full-text]
6. Contact sensitivity to standard series allergens in 1038 patients with contact dermatitis in Turkey.
   Contact Dermatitis, 52(6): 333-7. [Abstract] [Full-text]
7. Contact sensitivity to preservatives in Turkey.
   Contact Dermatitis, 52(6): 329-32. [Abstract] [Full-text]
8. Selected oxidized fragrance terpenes are common contact allergens.
   Contact Dermatitis, 52(6): 320-8. [Abstract] [Full-text]
9. Allergy to 3-nitro-p-hydroxyethylaminophenol and 4-amino-3-nitrophenol in a hair dye.
   Contact Dermatitis, 52(6): 317-9. [Abstract] [Full-text]
10. Phytodermatitis from Ceratocephalus falcatus.
    Contact Dermatitis, 52(6): 314-6. [Abstract] [Full-text]
11. Nickel contact allergy and menstrual cycle.
    Contact Dermatitis, 52(6): 309-13. [Abstract] [Full-text]
12. Severe contact urticaria to guar gum included as gelling agent in a local anaesthetic.
    Contact Dermatitis, 52(6): 307-8. [Abstract] [Full-text]
13. Sensitivity to Myroxylon pereirae resin (balsam of Peru). A study of 50 cases.
    Contact Dermatitis, 52(6): 304-6. [Abstract] [Full-text]
14. Are we reaching the limits or our ability to detect skin effects with our current testing and measuring methods for consumer products?
    Contact Dermatitis, 52(6): 297-303. [Abstract] [Full-text]
15. Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.
    Clin Exp Immunol, 140(3): 572-9. [Abstract] [Full-text]
16. Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome.
    Clin Exp Immunol, 140(3): 524-31. [Abstract] [Full-text]
17. Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment.
    Allergy, 60(7): 944-51. [Abstract] [Full-text]
18. The information needs and preferred roles in treatment decision-making of parents caring for infants with atopic dermatitis: a qualitative study.
    Allergy, 60(7): 938-43. [Abstract] [Full-text]
19. Diverging prevalence trends of atopic disorders in Norwegian children. Results from three cross-sectional studies.
    Allergy, 60(7): 894-9. [Abstract] [Full-text]
20. The effect of encasings on quality of life in adult house dust mite allergic patients with rhinitis, asthma and/or atopic dermatitis.
    Allergy, 60(7): 888-93. [Abstract] [Full-text]
21. Human TSLP promotes CD40 ligand-induced IL-12 production by myeloid dendritic cells but maintains their Th2 priming potential.
    Blood, 105(12): 4749-51. [Abstract] [Full-text]
22. Inhibition of angiogenesis in cancer patients.
    Expert Opin Emerg Drugs, 10(2): 403-12. [Abstract] [Full-text]
23. Kampo Medicines for Mite Antigen-Induced Allergic Dermatitis in NC/Nga Mice.
    Evid Based Complement Alternat Med, 2(2): 191-199. [Abstract] [Full-text]
24. Lymphocyte trafficking to inflamed skin -- molecular mechanisms and implications for therapeutic target molecules.
    Expert Opin Ther Targets, 9(2): 225-43. [Abstract] [Full-text]
25. Targets in allergy-directed immunotherapy.
    Expert Opin Ther Targets, 9(2): 217-24. [Abstract] [Full-text]
26. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
    J Allergy Clin Immunol, 115(6): 1276-83. [Abstract] [Full-text]
27. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects.
    J Allergy Clin Immunol, 115(6): 1268-75. [Abstract] [Full-text]
28. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin.
    J Allergy Clin Immunol, 115(6): 1260-7. [Abstract] [Full-text]
29. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome.
    J Allergy Clin Immunol, 115(6): 1254-9. [Abstract] [Full-text]
30. The role of breast-feeding in the development of allergies and asthma.
    J Allergy Clin Immunol, 115(6): 1238-48. [Abstract] [Full-text]
31. Diet as a risk factor for atopy and asthma.
    J Allergy Clin Immunol, 115(6): 1109-17; quiz 1118. [Abstract] [Full-text]
32. The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport.
    Eur J Pharm Biopharm, 60(2): 167-78. [Abstract] [Full-text]
33. Midaortic syndrome and celiac disease: a case of local vasculitis.
    Clin Rheumatol, 24(3): 301-4. [Abstract] [Full-text]
34. Critical appraisal of reports on the treatment of perioral dermatitis.
    Dermatology, 210(4): 300-7. [Abstract] [Full-text]
35. Psychophysiological reactivity under mental stress in atopic dermatitis.
    Dermatology, 210(4): 286-93. [Abstract] [Full-text]
36. The Influence of long-chain polyunsaturated fatty acids on total lipid fatty acid composition of a canine mastocytoma cell line.
    J Vet Med A Physiol Pathol Clin Med, 52(5): 219-24. [Abstract] [Full-text]
37. Anaphylaxis to povidone in a child.
    Pediatr Allergy Immunol, 16(4): 361-2. [Abstract] [Full-text]
38. Modest increase in seasonal allergic rhinitis and eczema over 8 years among Estonian schoolchildren.
    Pediatr Allergy Immunol, 16(4): 315-20. [Abstract] [Full-text]
39. Dapsone syndrome with acute renal failure during leprosy treatment: case report.
    Braz J Infect Dis, 9(1): 84-6. [Abstract] [Full-text]
40. Infantile eczema at one month of age is associated with cord blood eosinophilia and subsequent development of atopic dermatitis and wheezing illness until two years of age.
    Int Arch Allergy Immunol, 137: 69-76. [Abstract] [Full-text]
41. NR4A orphan nuclear receptor family in peripheral blood eosinophils from patients with atopic dermatitis and apoptotic eosinophils in vitro.
    Int Arch Allergy Immunol, 137: 35-44. [Abstract] [Full-text]
42. Recurrent V75M mutation within the Wiskott-Aldrich syndrome protein: description of a homozygous female patient.
    Eur J Haematol, 75(1): 54-9. [Abstract] [Full-text]
43. Candida albicans-specific lymphoproliferative and cytokine (IL-4 and IFN-gamma) responses in atopic eczema dermatitis syndrome. Evidence of CD4/CD8 and CD3/CD16+CD56 ratio elevations in vitro.
    Exp Dermatol, 14(7): 551-8. [Abstract] [Full-text]
44. Cystic lesion of the parotid following drug-induced toxic epidermal necrolysis (Lyell's syndrome).
    J Oral Pathol Med, 34(6): 380-2. [Abstract] [Full-text]
45. Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy.
    Br J Dermatol, 152(6): 1346-8. [Abstract] [Full-text]
46. Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial.
    Br J Dermatol, 152(6): 1296-303. [Abstract] [Full-text]
47. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Br J Dermatol, 152(6): 1282-9. [Abstract] [Full-text]
48. Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis.
    Br J Dermatol, 152(6): 1275-81. [Abstract] [Full-text]
49. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis.
    Br J Dermatol, 152(6): 1235-42. [Abstract] [Full-text]
50. Air flow at different temperatures increases sodium lauryl sulphate-induced barrier disruption and irritation in vivo.
    Br J Dermatol, 152(6): 1228-34. [Abstract] [Full-text]
51. Use of nonprescription topical steroids: patients' experiences.
    Br J Dermatol, 152(6): 1193-8. [Abstract] [Full-text]
52. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
    Br J Dermatol, 152(6): 1173-81. [Abstract] [Full-text]
53. Anxiety accelerates T-helper 2-tilted immune responses in patients with atopic dermatitis.
    Br J Dermatol, 152(6): 1161-4. [Abstract] [Full-text]
54. Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospital.
    Br J Clin Pharmacol, 59(6): 718-23. [Abstract] [Full-text]
55. Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis.
    Eur J Pharmacol, 516(2): 180-1. [Abstract] [Full-text]
56. Up-regulated phosphorylation of signal transducer and activator of transcription 3 and cyclic AMP-responsive element binding protein by peripheral inflammation in primary afferent neurons possibly through oncostatin M receptor.
    Neuroscience, 133(3): 797-806. [Abstract] [Full-text]
57. Clinical characteristics and surgical outcomes of pediatric rhegmatogenous retinal detachment in Taiwan.
    Am J Ophthalmol, 139(6): 1067-72. [Abstract] [Full-text]
58. Acroangiodermatitis (pseudo-Kaposi sarcoma) associated with verrucous hyperplasia induced by suction-socket lower limb prosthesis.
    J Cutan Pathol, 32(6): 429-32. [Abstract] [Full-text]
59. Coeliac disease presenting as dermatitis herpetiformis in infancy.
    J Paediatr Child Health, 41(5): 294-6. [Abstract] [Full-text]
60. Hypersensitivity reactions in neonates and infants.
    Dermatol Ther, 18(2): 160-75. [Abstract] [Full-text]
61. Diaper dermatitis that does not quit.
    Dermatol Ther, 18(2): 124-35. [Abstract] [Full-text]
62. Nutritional deficiencies and the skin.
    Clin Exp Dermatol, 30(4): 388-90. [Abstract] [Full-text]
63. A survey of bathing and showering practices in children with atopic eczema.
    Clin Exp Dermatol, 30(4): 351-4. [Abstract] [Full-text]
64. A comparison of narrowband (TL-01) UVB-induced erythemal response at different body sites.
    Clin Exp Dermatol, 30(4): 337-9. [Abstract] [Full-text]
65. Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species.
    J Clin Microbiol, 43(6): 2824-9. [Abstract] [Full-text]
66. The effect of solar-simulated radiation on the elicitation phase of contact hypersensitivity does not differ between controls and patients with polymorphic light eruption.
    J Invest Dermatol, 124(6): 1308-12. [Abstract] [Full-text]
67. Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases.
    J Invest Dermatol, 124(6): 1225-33. [Abstract] [Full-text]
68. Analysis of circulating gammadelta T cells in children affected by IgE-associated and non-IgE-associated allergic atopic eczema/dermatitis syndrome.
    Clin Exp Immunol, 141(1): 116-21. [Abstract] [Full-text]
69. Interleukin-4 induced down-regulation of skin homing receptor expression by human viral-specific CD8 T cells may contribute to atopic risk of cutaneous infection.
    Clin Exp Immunol, 141(1): 107-15. [Abstract] [Full-text]
70. Papular dermatitis due to Leishmania spp. infection in dogs with parasite-specific cellular immune responses.
    Vet Dermatol, 16(3): 187-91. [Abstract] [Full-text]
71. Cutaneous metastases of a bronchial adenocarcinoma in a cat.
    Vet Dermatol, 16(3): 183-6. [Abstract] [Full-text]
72. Comparison of the clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment of Malassezia dermatitis in dogs--a pilot study.
    Vet Dermatol, 16(3): 171-6. [Abstract] [Full-text]
73. Effectiveness of low dose immunotherapy in the treatment of canine atopic dermatitis: a prospective, double-blinded, clinical study.
    Vet Dermatol, 16(3): 162-70. [Abstract] [Full-text]
74. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.
    J Am Acad Dermatol, 53(1): 147-9. [Abstract] [Full-text]
75. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects.
    J Am Acad Dermatol, 53(1): 67-72. [Abstract] [Full-text]
76. Psoriasis herpeticum: three cases of Kaposi's varicelliform eruption in psoriasis.
    J Am Acad Dermatol, 53(1): 52-6. [Abstract] [Full-text]
77. Structure-activity models for contact sensitization.
    Chem Res Toxicol, 18(6): 954-69. [Abstract] [Full-text]
78. Total and specific serum IgE decreases with age in patients with allergic rhinitis, asthma and insect allergy but not in patients with atopic dermatitis.
    Immun Ageing, 2(1): 9. [Abstract] [Full-text]
79. Mobilisation of specific T cells from lymph nodes in contact sensitivity requires substance P.
    J Neuroimmunol, 164(1): 115-23. [Abstract] [Full-text]
80. An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: 2nd round.
    Toxicology, 212(1): 69-79. [Abstract] [Full-text]
81. Interleukin-10-secreting "regulatory" T cells induced by glucocorticoids and beta2-agonists.
    Am J Respir Cell Mol Biol, 33(1): 105-11. [Abstract] [Full-text]
82. JTP-27536 [(+)-1,3-dihydroxy-2-hydroxymethylpropyl-2-ammonium 2-[(R)-3-cyclo-hexyl-1-phenylpropyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylate monohydrate], a novel inhibitor of immunoglobulins and interleukin-5 with anti-inflammatory properties in mouse allergic dermatitis model.
    J Pharmacol Exp Ther, 314(1): 293-301. [Abstract] [Full-text]
83. Psoriasis--recent advances in understanding its pathogenesis and treatment.
    J Am Acad Dermatol, 53(1): S94-100. [Abstract] [Full-text]
84. Atopic dermatitis.
    J Am Acad Dermatol, 53(1): S86-93. [Abstract] [Full-text]
85. Involving the patient: impact of inflammatory skin disease and patient-focused care.
    J Am Acad Dermatol, 53(1): S78-85. [Abstract] [Full-text]
86. A clinician's paradigm in the treatment of atopic dermatitis.
    J Am Acad Dermatol, 53(1): S70-7. [Abstract] [Full-text]
87. Corticosteroids: options in the era of steroid-sparing therapy.
    J Am Acad Dermatol, 53(1): S50-8. [Abstract] [Full-text]
88. Therapeutic options in the treatment of psoriasis and atopic dermatitis.
    J Am Acad Dermatol, 53(1): S3-16. [Abstract] [Full-text]
89. Mechanisms of action of topical therapies and the rationale for combination therapy.
    J Am Acad Dermatol, 53(1): S17-25. [Abstract] [Full-text]
90. Incidence rates, costs, severity, and work-related factors of occupational dermatitis: a workers' compensation analysis of Oregon, 1990-1997.
    Arch Dermatol, 141(6): 713-8. [Abstract] [Full-text]
91. Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis.
    Arch Dermatol, 141(6): 683-7. [Abstract] [Full-text]
92. Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study.
    Clin Exp Allergy, 35(6): 741-5. [Abstract] [Full-text]
93. Perinatal risk factors for sensitization, atopic dermatitis and wheezing during the first year of life (PIPO study).
    Clin Exp Allergy, 35(6): 733-40. [Abstract] [Full-text]
94. Hexavalent chromium disrupts the actin cytoskeleton and induces mitochondria-dependent apoptosis in human dermal fibroblasts.
    Toxicol In Vitro, 19(6): 713-23. [Abstract] [Full-text]
95. Protective effects of different marigold (Calendula officinalis L.) and rosemary cream preparations against sodium-lauryl-sulfate-induced irritant contact dermatitis.
    Skin Pharmacol Physiol, 18(4): 195-200. [Abstract] [Full-text]
96. Canadian Practical Guide for the Treatment and Management of Atopic Dermatitis.
    J Cutan Med Surg. [Abstract] [Full-text]
97. The reported incidence of work-related ill-health in Scotland (2002-2003).
    Occup Med (Lond), 55(4): 252-61. [Abstract] [Full-text]
98. Cell death-induced activation of epidermal growth factor receptor in keratinocytes: implications for restricting epidermal damage in dermatitis.
    J Invest Dermatol, 125(1): 134-42. [Abstract] [Full-text]
99. Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis.
    J Invest Dermatol, 125(1): 68-71. [Abstract] [Full-text]
100. Atopic dermatitis--more than a simple skin disorder.
     J Am Acad Nurse Pract, 17(7): 249-55. [Abstract] [Full-text]
101. Phototoxic dermatitis due to Chenopodium album in a mother and son.
     Contact Dermatitis, 53(1): 58-60. [Abstract] [Full-text]
102. Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.
     Contact Dermatitis, 53(1): 53-5. [Abstract] [Full-text]
103. Allergic contact dermatitis from natural rubber latex in atopic dermatitis and the risk of later Type I allergy.
     Contact Dermatitis, 53(1): 46-51. [Abstract] [Full-text]
104. Patch test reactions to cosmetic allergens in 1995-1997 and 2000-2002 in Finland--a multicentre study.
     Contact Dermatitis, 53(1): 40-5. [Abstract] [Full-text]
105. 10 years' experience of patch testing with a shoe series in 230 patients: which allergens are important?
     Contact Dermatitis, 53(1): 37-9. [Abstract] [Full-text]
106. A temporary henna tattoo causing hair and clothing dye allergy.
     Contact Dermatitis, 53(1): 33-6. [Abstract] [Full-text]
107. Preservatives in registered chemical products.
     Contact Dermatitis, 53(1): 27-32. [Abstract] [Full-text]
108. Extraction of haptens from solid products and their delivery to the skin, exemplified by dithiocarbamates from rubber gloves.
     Contact Dermatitis, 53(1): 22-6. [Abstract] [Full-text]
109. Chemical exposure and symptoms of hand dermatitis in construction painters.
     Contact Dermatitis, 53(1): 14-21. [Abstract] [Full-text]
110. Unintended cutaneous reactions to CS spray.
     Contact Dermatitis, 53(1): 9-13. [Abstract] [Full-text]
111. Cross-reactivity between nickel and palladium demonstrated by systemic administration of nickel.
     Contact Dermatitis, 53(1): 2-8. [Abstract] [Full-text]
112. Ovalbumin-induced IL-4, IL-5 and IFN-gamma production in infants with atopic dermatitis.
     Int Arch Allergy Immunol, 137(2): 134-40. [Abstract] [Full-text]
113. Prominent involvement of activated Th1-subset of T-cells and increased expression of receptor for IFN-gamma on keratinocytes in atopic dermatitis acute skin lesions.
     Int Arch Allergy Immunol, 137(2): 125-33. [Abstract] [Full-text]
114. A laboratory investigation of the effectiveness of various skin and surface decontaminants for aliphatic polyisocyanates.
     J Environ Monit, 7(7): 716-21. [Abstract] [Full-text]
115. Vesiculous prurigo pigmentosa in a 13-year-old girl: good response to isotretinoin.
     J Eur Acad Dermatol Venereol, 19(4): 474-6. [Abstract] [Full-text]
116. Childhood granulomatous periorificial dermatitis: lupus miliaris disseminatus faciei in children?
     J Eur Acad Dermatol Venereol, 19(4): 470-3. [Abstract] [Full-text]
117. Reactivity to euro coins and sensitization thresholds in nickel-sensitive subjects.
     J Eur Acad Dermatol Venereol, 19(4): 449-54. [Abstract] [Full-text]

© 2004-2010 Skin Rashes Research Today. All Rights Reserved.